Genmab — Juli 2020

[E_L]

so it may even work in Ofa's advantage

[Solsen]

The advantage for ofa is obviously. Mainly due the low dose. But Roche is is powerfull competitor.

[Solsen]

Low dose - sc version with alle the advances and not depletion of all b-cells so infections wont be a problem. Ofa is a perfect drug for RRMS but not first mover. Exciting what Novatis can do in terms sales.

[Fritten]

Udover at casen bare er god, hvilke kurstriggere ned/op ser i så indenfor de næste 3-6 måneder?

[Solsen]

Data på PD-L1 x 4-1BB (Biontech samarbejdet) og ofa i RRMS er vigtige. Førstnævnte kan virkelig trække kursen, hvis data er så gode som vi håber. Jeg tror/håber, at det er nævnte data der gør, at JW tør udtale sig så positivt, som han gør. Andre data offentliggøres også indenfor 6 mdr.

[E_L]

yes, it will be very different going forward, the amount of data we'll have to track for Genmab, it used to be simple with only Dara

[E_L]

besides updates on what we got earlier this year, Tiso, with a possible BLA and data on other tumors, Epco, Enapotamab HexaDR5DR5...

[E_L]

in addition, we have a PDUFA for the Dara Candor regimen in November, filing Andromeda and some hope for Amivantamab BLA towards the end of the year...

[E_L]

BioNtech raising money again , Rights Offering for up to 6,681,850 Ordinary Shares Including Ordinary Shares Represented by American Depositary Shares

[Solsen]

Biontech have almost tha same valuation as Genmab. Someone made a good investment in the IPO !

[E_L]

they
sure did!

[StockBull]

https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/85254_ta_koere_planmaessigt.PNG kurstarget 2400

[Solsen]

Hvad gætter du at på udfaldet bliver, når Genmab forlader kanalen ?

[Helge_LarsenPI-redaktør]

Pharma har vendt rundt til negativt terræn efter en flot start på dagen.

[E_L]

@Solsen then the rising Wedge will just turn into a rising Channel, with an upper trendline already at around 2700 . easy.

[Solsen]

I take that

[Helge_LarsenPI-redaktør]

Me too.

[Solsen]

And yes Helge - someone besides me have to think its time for taking profit.

[E_L]

and i forgot earlier, i expect we hear something by August about what Genmab wants to do with Cami-t https://twitter.com/adctherapeutics/status/1285589645275865088

[gdn55]

Husk stilhed før stormen.